For the Inventor, By the Inventor

Enter assignee name

Ici Pharma

Calculating rank

USPTO Granted Patents = 80

Forward Citations = 663

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Graham C Crawley (20 out of 36 patents)

Philip N Edwards (19 out of 52 patents)

Frederic H Jung (17 out of 33 patents)

4. Jean-Marc M Girodeau (14 out of 15 patents)

5. David Waterson (12 out of 31 patents)

6. Pierre A Bruneau (12 out of 14 patents)

7. Thomas G Bird (12 out of 17 patents)

8. Keith Oldham (9 out of 23 patents)

9. Frederick H Jung (6 out of 6 patents)

10. Gareth Morse Davies (5 out of 23 patents)

11. Colin J Strawson (5 out of 9 patents)

12. Jean J Lohmann (5 out of 6 patents)

13. Robert I Dowell (5 out of 21 patents)

14. Jean C Arnould (4 out of 5 patents)

15. John F Kingston (4 out of 4 patents)

Core Competencies:

Heterocyclic Compounds

5-Lipoxygenase Inhibitors

Cephalosporins

Quinoxalinyl Derivatives

Thiazole Derivatives

Indole Derivatives

Bicyclic Derivatives

Benzothiaziny Derivatives

Sulphonamide Derivatives

Pyran Derivatives

Diarylether Derivatives

Cephalosporin Intermediates

80 patents: Sort by Forward Citations

1. 5519022 - .alpha., .alpha. dialkylbenzyl derivatives (1996-05-21),

2. 5484805 - Heterocyclene derivatives (1996-01-16),

3. 5462953 - Benzoxazolyl derivatives useful as 5-lipoxygenase inhibitors (1995-10-31),

4. 5446043 - Isoquinolyl, quinoxalinyl and quinazolinyl derivatives as inhibitors of (1995-08-29),

5. 5412093 - 3-heterocyclic thiomethyl cephalosporins (1995-05-02),

6. 5407945 - Pyran derivatives and their use as inhibitors of 5-lipoxygenase (1995-04-18),

7. 5403859 - Heterocyclic derivatives (1995-04-04),

8. 5403857 - Benzenesulphonamide derivatives having 5-lipoxygenase inhibitory activity (1995-04-04),

9. 5371220 - Bicyclo-heterocyclic intermediates for cephalosporin compounds (1994-12-06),

10. 5364877 - Indole derivatives as 5-lipoxygenase inhibitors (1994-11-15),

11. 5359063 - Heterocyclene derivatives (1994-10-25),

12. 5350754 - Heterocyclic cycloalkanes (1994-09-27),

13. 5348951 - Cephalosporins (1994-09-20),

14. 5321025 - Benzothiaziny derivatives (1994-06-14),

15. 5314891 - Benzenesulphonamide derivatives (1994-05-24),

Company Overview

Ici Pharma, based in Cergy, France, specializes in the development and manufacturing of innovative pharmaceutical solutions, particularly focusing on heterocyclic compounds. The company is recognized for its expertise in various core technology topics, including 5-lipoxygenase inhibitors and a range of derivatives such as cephalosporins, quinoxalinyl, thiazole, indole, bicyclic, and benzothiaziny derivatives. Ici Pharma is committed to advancing therapeutic options through its research in these specialized chemical domains.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

80 Patents

#2 in Cergy

#328 in France

#9,460 in the World

Ici Pharma

Forward Citations = 663

36 inventors:

Graham C Crawley (20 out of 36 patents)

Philip N Edwards (19 out of 52 patents)

Frederic H Jung (17 out of 33 patents)

4. Jean-Marc M Girodeau (14 out of 15 patents)

5. David Waterson (12 out of 31 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ici Pharma. Retrieved from https://idiyas.com/company/ici-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…